CHPF and colorectal carcinoma: MiR-214-3p was similarly reduced in expression in CRC and correlated with adverse outcomes in CRC patients, it was shown that miR-214-3p directly targets chondroitin polymerizing factor and negatively regulates its expression in CRC cells, which in turn promotes ferroptosis and inhibits the growth of CRC cells [137].